HYPOURICEMIC EFFECT OF ZUCLOPENTHIXOL - A POTENTIAL MARKER OF DRUG COMPLIANCE

被引:9
作者
BLOCH, M [1 ]
GUR, E [1 ]
SHALEV, AY [1 ]
机构
[1] HADASSAH UNIV HOSP, DEPT PSYCHIAT, POB 12000, IL-91120 JERUSALEM, ISRAEL
关键词
ZUCLOPENTHIXOL; NEUROLEPTICS; SIDE-EFFECTS; URIC ACID; URICOSURIC AGENTS; NONCOMPLIANCE;
D O I
10.1007/BF02245887
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Twelve newly-admitted psychotic patients were treated with clinical doses of zuclopenthixol (ZPT). Plasma uric acid (PUA) was measured before and during treatment. ZPT reduced PUA in all the patients by an average of 29.6 % (P < 0.0001). PUA levels during treatment correlated with those obtained before treatment (R = 0.871, P < 0.0002). PUA returned to initial levels on discontinuation of treatment. Uric acid excretion increased during treatment. It is concluded that ZPT is a potent uricosuric agent, capable of producing persistent hypouricemia while administered. Such hypouricemia might be a useful indicator of drug compliance.
引用
收藏
页码:377 / 378
页数:2
相关论文
共 11 条
[1]  
AMDISEN A, 1986, PSYCHOPHARMACOLOGY, V90, P412
[2]   LONG-TERM DEPOT MAINTENANCE OF CHRONIC-SCHIZOPHRENIC OUT-PATIENTS - THE 7-YEAR FOLLOW-UP OF THE MEDICAL-RESEARCH-COUNCIL FLUPHENAZINE PLACEBO TRIAL .1. COURSE OF ILLNESS, STABILITY OF DIAGNOSIS, AND THE ROLE OF A SPECIAL MAINTENANCE CLINIC [J].
CURSON, DA ;
BARNES, TRE ;
BAMBER, RW ;
PLATT, SD ;
HIRSCH, SR ;
DUFFY, JC .
BRITISH JOURNAL OF PSYCHIATRY, 1985, 146 (MAY) :464-480
[3]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].
DAHL, SG .
CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61
[4]   CLINICAL-PHARMACOLOGY OF ADINAZOLAM AND N-DESMETHYLADINAZOLAM MESYLATE AFTER SINGLE ORAL DOSES OF EACH COMPOUND IN HEALTHY-VOLUNTEERS [J].
FLEISHAKER, JC ;
FRIEDMAN, H ;
POLLOCK, SR ;
SMITH, TC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (06) :652-654
[5]  
HOGARTY GE, 1973, ARCH GEN PSYCHIAT, V28, P54
[7]   PERPHENAZINE DECANOATE AND CIS(Z)-FLUPENTIXOL DECANOATE IN MAINTENANCE TREATMENT OF SCHIZOPHRENIC OUTPATIENTS - SERUM LEVELS AT THE MINIMUM EFFECTIVE DOSE [J].
KISTRUP, K ;
GERLACH, J ;
AAESJORGENSEN, T ;
LARSEN, NE .
PSYCHOPHARMACOLOGY, 1991, 105 (01) :42-48
[8]   ACUTE OLIGURIA ASSOCIATED WITH CHLORPROTHIXENE OVERDOSAGE [J].
SCHEITHAUER, W ;
ULRICH, W ;
KOVARIK, J ;
STUMMVOLL, HK .
NEPHRON, 1988, 48 (01) :71-73
[9]   THE HYPOURICEMIC EFFECT OF CHLORPROTHIXENE [J].
SHALEV, A ;
HERMESH, H ;
MUNITZ, H .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :562-566
[10]  
SHALEV A, 1989, J CLIN PSYCHIAT, V50, P424